AU8764191A - Ibuprofen-antihistamine combinations - Google Patents
Ibuprofen-antihistamine combinationsInfo
- Publication number
- AU8764191A AU8764191A AU87641/91A AU8764191A AU8764191A AU 8764191 A AU8764191 A AU 8764191A AU 87641/91 A AU87641/91 A AU 87641/91A AU 8764191 A AU8764191 A AU 8764191A AU 8764191 A AU8764191 A AU 8764191A
- Authority
- AU
- Australia
- Prior art keywords
- ibuprofen
- antihistamine
- combinations
- antihistamine combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58924190A | 1990-09-28 | 1990-09-28 | |
| US58924590A | 1990-09-28 | 1990-09-28 | |
| US589241 | 1990-09-28 | ||
| US589245 | 1990-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU8764191A true AU8764191A (en) | 1992-04-28 |
Family
ID=27080486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU87641/91A Abandoned AU8764191A (en) | 1990-09-28 | 1991-09-25 | Ibuprofen-antihistamine combinations |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0550668A4 (en) |
| JP (1) | JPH06502166A (en) |
| AU (1) | AU8764191A (en) |
| CA (1) | CA2092566A1 (en) |
| WO (1) | WO1992005783A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0663819A4 (en) * | 1992-09-29 | 1998-05-27 | Merck & Co Inc | IBUPROFEN-COFFEINE COMBINATIONS. |
| CA2149317A1 (en) * | 1992-12-21 | 1994-07-07 | Richard Wilfred D'souza | Compositions and method for providing improved analgesic effect |
| CN1060040C (en) * | 1993-10-25 | 2001-01-03 | 默里尔药物公司 | A stable pharmaceutical composition of terfenadine and isuprofen |
| AU1716995A (en) * | 1994-03-18 | 1995-10-09 | Ciba-Geigy Ag | Aqueous solution of levocabastine for ophthalmic use |
| EP0841947A1 (en) * | 1995-07-28 | 1998-05-20 | The Procter & Gamble Company | Compositions containing analgesics and antihistamines and methods for treating respiratory disorders |
| JP4614638B2 (en) * | 2002-06-07 | 2011-01-19 | 第一三共株式会社 | Analgesic composition |
| JP4614640B2 (en) * | 2002-07-04 | 2011-01-19 | 第一三共株式会社 | Antipyretic composition |
| JP2010159299A (en) * | 2002-07-04 | 2010-07-22 | Daiichi Sankyo Co Ltd | Antipyretic composition comprising loxoprofen and ketotifen |
| PL2240018T3 (en) | 2008-01-04 | 2017-01-31 | Schabar Res Ass Llc | ANTI-PAIN AND ANTI-HISTAMIN AGENT COMPOSITION |
| AU2009251743A1 (en) * | 2008-05-30 | 2009-12-03 | Fairfield Clinical Trials, Llc | Method and composition for skin inflammation and discoloration |
| US8957095B2 (en) | 2009-10-26 | 2015-02-17 | Sephoris Pharmaceuticals, Llc | Treatment of sunburn using analgesics and antihistamines |
| AU2016235484B2 (en) * | 2015-03-26 | 2021-02-18 | Jacqueline M. Iversen | Methods and compositions to inhibit symptoms associated with veisalgia |
| WO2022015784A1 (en) | 2020-07-15 | 2022-01-20 | Schabar Research Associates Llc | Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn |
| US12514846B2 (en) | 2020-07-15 | 2026-01-06 | Schabar Research Associates Llc | Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach |
| CA3124579A1 (en) | 2020-07-15 | 2022-01-15 | Schabar Research Associates Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
| MX2022015332A (en) * | 2020-12-04 | 2023-01-11 | Laboratorios Silanes S A De C V | PHARMACEUTICAL COMPOSITION OF AN ANALGESIC AND AN ANTIHISTAMINE FOR THE TREATMENT OF RESPIRATORY DISEASES. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783465A (en) * | 1984-04-09 | 1988-11-08 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
| DE3639038C2 (en) * | 1986-11-14 | 1997-02-06 | Helmut Dr Lukas | Use of S - (+) - ibuprofen for rapid treatment of human pain |
| US4851444A (en) * | 1987-07-10 | 1989-07-25 | Analgesic Associates | Onset-hastened/enhanced analgesia |
| US4980375A (en) * | 1987-07-10 | 1990-12-25 | Sterling Drug Inc. | Onset-hastened/enhanced antipyretic response |
-
1991
- 1991-09-25 JP JP3517917A patent/JPH06502166A/en active Pending
- 1991-09-25 WO PCT/US1991/007007 patent/WO1992005783A1/en not_active Ceased
- 1991-09-25 AU AU87641/91A patent/AU8764191A/en not_active Abandoned
- 1991-09-25 EP EP19910918783 patent/EP0550668A4/en not_active Withdrawn
- 1991-09-25 CA CA002092566A patent/CA2092566A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0550668A1 (en) | 1993-07-14 |
| CA2092566A1 (en) | 1992-03-29 |
| EP0550668A4 (en) | 1993-10-13 |
| JPH06502166A (en) | 1994-03-10 |
| WO1992005783A1 (en) | 1992-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU639126B2 (en) | Oxorapamycin | |
| AU8791591A (en) | Tnf-muteins | |
| AU7846991A (en) | Aminobenzodiazepines | |
| AU8017991A (en) | Structural elements | |
| AU7867491A (en) | Compounds | |
| AU8764191A (en) | Ibuprofen-antihistamine combinations | |
| AU7956191A (en) | Transportsystem | |
| AU7804691A (en) | N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas | |
| AU9030991A (en) | Improved capacitor-sensor | |
| AU1080292A (en) | Ige-receptor-antibodies | |
| AU7726391A (en) | Slitterscorer | |
| AU1766292A (en) | Ibuprofen-decongestant combinations | |
| AU6531090A (en) | Swagable fitting | |
| AU8624791A (en) | Compounds | |
| AU6498390A (en) | Improved packerhead assembly | |
| AU8740291A (en) | 3d-spectacles | |
| AU7566691A (en) | Compostor | |
| AU7587991A (en) | Electrodermatome | |
| AU8984191A (en) | Thiadiazinones | |
| AU8516291A (en) | Instant photograph-postcard | |
| AU7752291A (en) | Stay | |
| AU7709991A (en) | Phenoxyphenylsulphonyl compounds | |
| AU8710691A (en) | Ibuprofen-diuretic combinations | |
| AU7922191A (en) | 2-acylamino-7-chlorobenzothiazoles | |
| AU8657991A (en) | Hand-saws |